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Abstract The effect of NO on phosphotyrosine protein 
phosphatases (PTPases) has been investigated in vivo. NO pro- 
duction is induced in interferon-y and lipopolyaccharide stimu- 
lated RAW-264.7 macrophages as indicated by the increase of 
NO~ in the medium. Our results demonstrate an inhibition of 
p-nitrophenylphosphatase activity as a consequence of macro- 
phages activation. Under the described experimental conditions, 
most of the hydrolysis ofp-nitrophenylphosphate can be ascribed 
to the action of cellular PTPases. The presence of N~-mono - 
methyI-L-arginine, a specific inhibitor of NO synthase decreases 
the inactivation rate of both membrane-bound and soluble 
PTPases. This evidence further confirms the ability of NO to 
inactivate PTPases and suggests a possible role of NO in the 
regulation of cellular processes involving this class of 
phosphatases. 
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1. Introduction 
Nitric oxide (NO) is rapidly emerging as one of the main 
cellular regulators. It is produced from L-arginine in macro- 
phages, endothelial cells and other cell types, and has been 
implicated in several physiological processes including vascular 
smooth muscle relaxation, inhibition of platelet aggregation, 
neurotransmission, immune regulation and penile erection 
[1,2]. Girard and Potier suggested also that the NO-mediated 
S-nitrosation could play a role in interconversion of thiol 
groups and disulfides in chain radical or oxidation-reduction 
processes that improve protein structural stability, ensure enzy- 
matic catalysis, transport of reducing equivalents, and meta- 
bolic regulation [3]. The biological functions of NO are proba- 
bly mediated by an array of interrelated redox forms such as 
the nitrosonium cation (NO+), nitric oxide (NO'), and nitroxyl 
anion (NO-). These forms may be interconverted through 
redox reactions [2]. Several authors reported that the S-nitrosa- 
tion of enzymes and membrane receptors is involved in the 
regulation of these systems [4~7]. Clearly, the S-nitrosation of 
proteins and other thiol-containing compounds i caused by the 
nitrosonium ion [2,8]. 
Recently, we demonstrated that NO causes in vitro inactiva- 
tion of the low M r and Yersinia enterocolitica PTPases [9]. The 
inactivation of  the enzymes is determined by the reaction of NO 
with the highly reactive cysteine residue present in the active site 
of all PTPase family members [I0]. In fact, all PTPases possess 
the evolutionary conserved active site moti f  CXXXXXR form- 
*Corresponding author. Fax: (39) (55) 4222725. 
E-mail: DPT_BIOCH@CESIT 1 .UNIFI.IT 
ing a three-dimensional phosphate binding loop that is essential 
for catalysis [11,12]. The structural analysis performed on the 
modified low Mr PTPase showed that a disulphide bridge be- 
tween Cys-12 and Cys-17 (both induced in the conserved loop) 
was formed during the action of NO on the enzyme [9]. We also 
demonstrated that the inactivation is reverted by incubation of 
the modified enzyme with low molecular weight thiols, suggest- 
ing that nitric oxide can cause a transient inactivation of 
PTPases. The aim of this paper is to investigate the possible in 
vivo involvement of NO in the regulation of PTPase activity in 
cells. It is well known that macrophage activation by interferon- 
~, and bacterial ipopolysaccharides, induces the NO synthase 
activity [13]. Thus, this work describes the effect of murine 
macrophage activation on the activity of cellular PTPases. 
2. Materials and methods 
2.1. Reagents 
N-Monomethyl-L-arginine was obtained from Sigma. Interferon-~' 
was from Amgen, Thousand Oaks, CA. All other reagents were the 
purest commercially available. 
2.2. RA W 264. 7 cell culture stimulation, and fractionation 
RAW 264.7, an Abelson virus-transformed murine macrophage c ll 
line (American Type Culture Collection, ATCC TIB71), was cultured 
in Dulbecco's modified Eagles medium containing 4.5 g/1 glucose, 2 mM 
glutamine, supplemented with 10% fetal calf serum (PBI) and antibiot- 
ics (50 units/ml penicillin-G, 50/.tg/ml streptomycin). Activation exper- 
iments were performed in Phenol red-free medium by incubating the 
cells (70-80%) confluence) with bacterial lipopolysaccharide (LPS from 
E. coli subtype 0127:B8, SIGMA) 1 Bg/ml and recombinant mouse 
interferon-7 50 units/ml. 
The cytosolic and detergent-dissolved membrane fractions were pre- 
pared from cells; after removal of the medium, cells were washed twice 
with 1 ml of ice-cold phosphate buffered saline, then collected in 0.3 ml 
of 20 mM Tris-HC1 buffer, pH 7.2, containing 0.1% 2-mercaptoethanol, 
2 mM EDTA, 1 mM PMSF, 20 mM leupeptine, 5/lg/ml aprotinin. 
Cell suspensions were sonicated with two bursts of 10 s with a Vibra- 
Cell (Sonics and Materials Inc, Danbury, CT, USA). The lysates were 
centrifuged for 45 min at 100,000 xg and 4°C. Supernatants were 
assayed for protein concentration and enzymatic activity. The pellets 
were suspended in 0.3 ml of the same buffer containing 1% Triton 
X-100 and centrifuged for 10 min at 12,550 x g. Portions of the super- 
natant were assayed for protein concentration and activity. 
2.3. Cell viability test 
Cellular viability was tested by Trypan-blue staining. About 1 x 105 
cells were resuspended in 1 ml of PBS (phosphate buffer saline) and 
trypan-blue reagent (1% Trypan-blue in PBS) was added at the 1 : 1 
ratio. After 10 min incubation on ice, cells were screened for viability 
by visible-light microscopy. Dead cells were blue-stained, while alive 
cells remained white and light-refracting. 
2.4. Nitrite ion determination 
NO release in the culture media was determined as nitrite production 
using the Greiss reagent that contains 0.5% sulphanylamide and 0.05% 
N-(1-naphthyl-ethylendiamine dihydrochloride in 2.5% phosphoric 
acid [14]. The Greiss reagent (150/A) was added to 150/11 of medium, 
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and the absorbance was read after 10 min at 492 nm using a 96-well 
microplate reader. 
2.5. Protein determination 
Protein concentration was determined by the BCA method (Pierce). 
2.6. Determination of PTPase activity 
Phosphatase activity was determined using p-nitrophenyl phosphate 
as substrate (this substrate is hydrolysed by all PTPases). The substrate 
(4 mM) was dissolved in 25 mM Tris-HC1 buffer, pH 7.2, containing 
1 mM EDTA, 0.1% 2-mercaptoethanol, 20 mM sodium-potassium 
DL-tartrate and 1 tiM okadaic acid. The reaction was stopped with 0.1 
M KOH and the released p-nitrophenolate ion was measured by read- 
ing the absorbance at 400 nm (e = 18,000 M-l'cm ~). The activity 
measured in these conditions was completely inhibited by 100 ,uM 
orthovanadate, a specific and strong inhibitor of all PTPases [15]. 
3. Results 
3.1. NO-mediated inactivation of  PTPases in the murine 
macrophage cell line RA W264. 7 stimulated with 
lipopolysaccharide and interferon-), 
The murine macrophages were stimulated with lipopolysac- 
charide (LPS, 1 ¢tg/ml) and interferon-), (50 U/ml) in order to 
induce NO-synthase followed by the formation of NO in the 
cells [13]. At varying time intervals the NO2 ion was assayed in 
the cell medium in order to test NO release from macrophages. 
At the same time, the cultured cells were lysed with 0.3 ml of 
20 mM Tris-HC1 buffer, pH 7,2, containing 0.1% 2-mercap- 
toethanol, 2 mM EDTA, 1 mM PMSF, 20 mM leupeptin and 
5 ¢tg/ml aprotinine. The mixture was centrifuged at 12,550 x g, 
and the phosphatase activity was assayed with p-nitrophenyl 
phosphate as substrate in the presence of tartrate, EDTA, and 
okadaic acid in order to inhibit lysosomal acid phosphatases 
and non-specific phosphatases. Under these conditions we were 
sure of the assay specificity for PTPases. In fact, all the assays 
were repeated in the presence of 100 ¢tM orthovanadate, a well 
known specific strong inhibitor of all PTPases, leaving a negli- 
gible residualp-nitrophenylphosphatase ac ivity. Fig. 1A shows 
the increase in NO2 concentration i  the cell culture medium 
as a function of incubation time. As can be seen, the concentra- 
tion of this ion increased continuously starting from 3 h until 
24 h of incubation time, reaching the maximum concentration 
of about 60 ¢tM in the LPS and interferon-), stimulated cells, 
whereas in the non- stimulated cells the NO~ ion concentration 
showed only a slight increase. With respect o PTPase activity, 
we observed an initial increase in the 0-3 h period both in the 
unstimulated and stimulated cells. Nevertheless, at 15 and 24 
h of incubation time the activity found in the LPS and inter° 
feron-), stimulated cells was strongly decreased, whereas that 
of unstimulated cells remained quite constant (Fig. I B). We 
selected the 24 h incubation time in order to perform further 
tests on the RAW-264.7 macrophages. Particularly, we studied 
the effect of cell stimulation i the presence of N~-monomethyl - 
L-arginine (NMA), a powerful specific inhibitor of NO-syn- 
thase. The inhibitor was added to the culture medium at the 
final concentration f 1 raM. Furthermore, the PTPase activity 
was assayed both in the soluble and particulate fractions, since 
PTPases are located both in the cell membrane and in the 
cytosol. Fig. 2A and 2B show the results obtained by assaying 
the membrane-bound and the soluble PTPase activities respec- 
tively. We found similar esults for membrane-bound and solu- 
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Fig. 1. Inactivation of PTPases in macrophage c ll line RAW 264.7 by 
NO. Cells were incubated for the indicated times either in DMEM alone 
(<~) or in the same medium supplemented with 50 U/ml interferon-z and 
1/.tg/ml bacterial lipopolysaccharide (o).The latter treatment increased 
NO release, measured as nitrite using Greiss reagent (A). A concomi- 
tant decrease inPTPase specific activity (mU/mg of proteins) was ob- 
served (B). 
crease in PTPase activity and NMA substantially reduced the 
observed PTPase inactivation. This is in agreement with the 
reduced production of NO in the NMA-treated cells as demon- 
strated by the reduced release of the NO 2 ion in the culture 
medium (Fig. 2C). 
4. Discussion 
Previous in vitro experiments performed in our laboratory 
demonstrated that both the isoenzymes of low Mr PTPases 
(AcP1 and AcP2 from rat liver) and Yersinia enterocolitica 
PTPase are inactivated by NO-producing compounds and NO 
gas [9]. The low M r PTPase inactivation is caused by a specific 
reaction of NO with active site cysteine(s) to form a S-nitroso- 
thiol; this is followed by the formation of an S-S bridge between 
Cys-12 and Cys-17. These residues are included in the active site 
signature motif CXXXXXR (residues 12-18 in the low Mr 
PTPase) present in all PTPase family members; Cys-12 and 
Arg-18 are essential for catalysis [10]. We suggested that the low 
M,. PTPase inactivation, which can be reverted by low molecu- 
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Fig. 2. Effect of cell stimulation i the presence ofNO sinthase-specific 
inhibitor NMA. Cells were incubated for 24 h in DMEM alone ([]) or 
in the same medium supplemented with 50 U/ml interferon-T and 
1/.tg/ml bacterial lipopolysaccharide (~-~) or with 50 U/ml interferon-y, 
1 /lg/ml bacterial lipopolysaccharide and 1 mM NMA (m). NMA 
decreased the inactivation rate of both membrane-bound (A) and solu- 
ble PTPases (B) with respect to that observed instimulated cells. In the 
NMA-treated cells we observed a reduced production of NO (C). 
lar weight thiols, is first caused by the reaction of the very 
reactive Cys-12 with NO leading successively to the formation 
of the observed S S bridge. Very reactive thiols were implicated 
by other authors in the reaction of enzymes [4-6] or membrane 
receptors [7] thiols to form S-nitroso-thiols. This paper demon- 
strates that macrophage PTPases, all containing a very reactive 
cysteine in the active site signature motif, are inactivated invivo 
following cell stimulation by LPS and interferon-y. It is known 
that cell activation causes NO production, as we also demon- 
strated in Fig. 1. The release of NO~ ions is related to NO 
production in the cell; NO2 concentration i  the culture me- 
dium is not a measure of NO level in the cell, since NO has free 
radical structure, and it is a short-living specie. It reacts rapidly 
with water-dissolved oxygen to form NO2, subsequently react- 
ing with water producing both NO~ and NO3 ions. The intracel- 
lularly generated NO is often lower than nanomolar [16]; thus 
our findings indicate that the inactivation of PTPases occurs 
not only in vitro but also in vivo conditions. Since we demon- 
strate that the inhibition of low Mr PTPase can be reverted by 
low molecular weight hiols, we suggest that the inactivation of
cellular PTPases is a transient phenomenon. These enzymes can 
regain their original activity through the action of intracellular 
low molecular weight hiols, like cysteine and reduced glutathi- 
one. In agreement with Girard and Potier [3], we think that the 
reversible covalent modification of reactive protein thiols, ei- 
ther to produce S-nitrosothiols or to produce S-S bridges, 
represents a new interesting type of regulation of biological 
functions. We underline that the continuously increasing NO~ 
concentration i dicates that RAW-264.7 macrophages were 
still living during the time of our experiments; in fact, the death 
of these cells is accompanied bythe decrease in the NO produc- 
tion rate as demonstrated by Stuehr and Marletta [17]. How- 
ever, we performed viability tests 24 h after cell activation. We 
found that about 95% of the cells were alive. 
Recently, Peranovich et al. [18] observed the in vivo inhibi- 
tion of the EGF-receptor PTPase activity in the HER 14 cell line 
incubated with sodium nitroprusside. These cells are murine 
fibroblasts expressing the human EGF-receptor. They found 
that increasing concentrations of NO are correlated with a 
gradual inhibition of PTPase activity in these cells, either in 
intact cells or in cell lysates. These findings uggest that the in 
vivo inhibition of PTPases by NO is not limited to the RAW 
264.7 murine macrophages, but probably extended to all cells. 
NO is a small molecule involved in several physiological proc- 
esses uch as the inhibition of platelet aggregation, desensitisa- 
tion of neurones to excess stimulation by glutamate, smooth 
muscle relaxation, and penile erection [1,2]. On the other hand, 
PTPases are known to be involved in the regulation of mito- 
genic signals acting on tyrosine kinase membrane receptors. 
Recently, we demonstrated that the low Mr PTPases are impli- 
cated in the down-regulation f the platelet derived growth 
factor receptor. In fact, the level of phosphotyrosine in BB- 
PDGF-stimulated NIH/3T3 fibroblasts overexpressing this en- 
zyme is strongly reduced with respect o normal cells [19]. In 
addition, we found that a dominant negative gene (which pro- 
duce a catalytically inactive nzyme that is still able to bind 
substrates) overexpressed in the above cell line forms a complex 
with the PDGF receptor [20]. 
Finally, we think that the action of NO on PTPases in vivo 
should be taken into great consideration, since more than forty 
different PTPases were discovered in the cells, most of them 
involved in the control of mitogenic signalling and others, such 
as the product of the cdc25 gene, essential in the control of the 
cell cycle and in other important biological functions. 
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